核苷(酸)类似物耐药与乙型肝炎病毒表面抗原变异
被引量:4
摘要
HBsAg变异是HBV研究的热点之一,但既往研究主要关注HBsAg变异与疫苗乙型肝炎免疫球蛋白(HBIG)逃逸、HBsAg诊断试剂以及隐匿性HBV感染的关系等。实际上,在HBV基因组中,HBsAg的编码序列与反转录酶(Rt)的编码序列完全重叠,因此Rt变异有可能造成HBsAg的相应变异。
出处
《中华传染病杂志》
CAS
CSCD
北大核心
2010年第5期318-320,共3页
Chinese Journal of Infectious Diseases
参考文献15
-
1Pawlotsky JM.The concept of hepatitis B virus mutant escape.J Clin Virol,2005,34 Suppl 1:S125-S129.
-
2Coleman PF.Detecting hepatitis B surface antigen mutants.Emerg Infect Dis,2006,12:198-203.
-
3Bauer T,Weinberger K,Jilg W.Variants of two major T cell epitopes within the,hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals.Hepatology,2002,35:455-465.
-
4Torresi J,Earnest-Silveira L,Deliyannis G,et al.Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy.Virology,2002,293:305-313.
-
5Sheldon J,Ramos B,Garcia-Samaniego J,et al.Selection of hepatitis B virus (HBV) vaccine escape mutants in HBVinfected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.J Acquir Immune Defic Syndr,2007,46,279-282.
-
6Sloan RD,Ijaz S,Moore PL,et al.Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.Antivir Ther,2008,13:439-447.
-
7Lee SY,Choi MS,Lee D,et al.Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy.J Korean Med Sci,2005,20:433-437.
-
8Hsu CW,Yeh CT,Chang ML,et al.Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.Gastroenterology,2007,132:543-550.
-
9Vietheer PT,Netter HJ,Sozzi T,et al.Failure of the lamivudine-resistant rtM204I hepatitis B virus mutants to efficiently support hepatitis delta virus secretion.J Virol,2005,79:6570-6573.
-
10Komla-Soukha I,Sureau C.A tryptophan-rich motif in the carboxyl terminus of the small envelope protein of hepatitis B virus is central to the assembly of hepatitis delta virus particles.J Virol,2006,80:4648-4655.
同被引文献36
-
1Ganem D,Prince AM. Hepatitis B virus infection - natural historyand clinical consequences[J]. N Engl J Med,2004,350( 11) : 1118-1129.
-
2Lok AS* McMahon BJ. Chronic hepatitis B[J]. Hepatology, 2007 ,45(2):507-539.
-
3McMahon BJ. Natural history of chronic hepatitis B[J]. Clin LiverDis,2010,14(3):381-396.
-
4Fung J, Lai CL,Seto WK, et al. Nucleoside/nucleotide analoguesin the treatment of chronic hepatitis B[J]. J Antimicrob Chemoth-er, 2011,66(12) : 2715-2725.
-
5Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues[J], Gastroenterology,2009,137(5) : 1593-1608.
-
6Locarnini S, Zoulim F. Molecular genetics of HBV infection[J].Antivir Ther,2010,15(Suppl 3) :3-14.
-
7European Association for the study of the liver. EASL clinicalpractice guidelines : management of chronic hepatitis B virus infec-tion[J]. J Hepatol,2012,57(1) : 167-185.
-
8Mauss S, Berg T, Rockstroh J, et al. Hepatology 2012 : a clinicalTextbook[M], Germany:Flying Publisher,2012 : 66-70.
-
9Dienstag JL. Hepatitis B virus infection[J]. N Engl J Med,2008,359(14):1486-1500.
-
10Kay A,Zoulim F. Hepatitis B virus genetic variability and evolu-tion[J], Virus Res,2007 ,127(2) : 164-176.
引证文献4
-
1俞杨,邬兰,焦杰,颜宁,杜同信,王自正.乙型肝炎病毒耐药突变对病毒表面抗原编码区的影响[J].国际检验医学杂志,2013,34(12):1518-1520. 被引量:7
-
2钱福初,秦基取,李栋立,王伟洪,戴利成.拉米夫定治疗后慢性乙肝患者HBV基因组RT区和S区变异分析[J].病毒学报,2015,31(4):433-439. 被引量:7
-
3庞亚博,汪莉萍.HBV RT区耐药变异对HBsAg的影响[J].胃肠病学和肝病学杂志,2018,27(10):1191-1194. 被引量:2
-
4庞亚博,刘影,彭华彬,李莎,汪莉萍,韩方正.rtA181V和rtA181T两种耐药模式的CHB患者血清HBsAg水平比较[J].现代医学,2018,46(8):853-857.
二级引证文献16
-
1丁岗强,康谊,刘俊平,曾艳丽,侯环荣,魏君锋,尚佳.乙肝病毒耐药导致慢性重型肝炎的抗病毒治疗临床疗效分析[J].中国医学创新,2014,11(8):6-8. 被引量:9
-
2邵君,王伟佳.乙型病毒肝炎实验室诊断的分析和研究进展[J].国际检验医学杂志,2014,35(20):2801-2804. 被引量:5
-
3刘萍萍.乙型肝炎病毒耐药的研究进展[J].医学检验与临床,2015,0(3):53-57.
-
4刘萍萍,王云.青岛地区乙型肝炎病毒耐药变异及相关因素分析[J].青岛大学医学院学报,2015,51(6):643-646.
-
5刘文宣,高霞,李保欣,李涛,刘文聪,张晓琳.拉米夫定治疗慢性乙型肝炎预后与HLA-DQ基因多态性的分析[J].河北医科大学学报,2015,36(12):1371-1374. 被引量:1
-
6喻慧铭,盛吉芳.e抗原阴性慢性乙肝老年患者核苷类药物停药后的临床和病毒学复发评估[J].中国老年学杂志,2016,36(6):1393-1395. 被引量:7
-
7张新华,关翠英,古力.艾麦特,王亚男,哈力旦.玉努斯江.汉族和维吾尔族乙型肝炎病毒耐药基因的相关临床研究[J].现代生物医学进展,2016,16(30):5945-5947. 被引量:1
-
8李全双,邓演超,程星,裴蕴锋,周静,沈红艳,徐湛.核苷(酸)类似物治疗停药后复发的慢性乙肝患者HBV逆转录酶区耐药突变分析[J].中国医药导报,2017,14(23):107-110. 被引量:2
-
9庞亚博,汪莉萍.HBV RT区耐药变异对HBsAg的影响[J].胃肠病学和肝病学杂志,2018,27(10):1191-1194. 被引量:2
-
10庞亚博,刘影,彭华彬,李莎,汪莉萍,韩方正.rtA181V和rtA181T两种耐药模式的CHB患者血清HBsAg水平比较[J].现代医学,2018,46(8):853-857.
-
1王建设,朱启镕.乙型肝炎病毒表面抗原变异的临床意义[J].肝脏,1999,4(4):244-246. 被引量:10
-
2王建设,朱启镕.乙型肝炎表面抗原变异和乙肝疫苗免疫失败[J].世界感染杂志,2002,2(4):206-208.
-
3姚昕,周诚,祁自柏.乙型肝炎病毒表面抗原变异对免疫诊断试剂检测结果的影响[J].中国生物制品学杂志,2009,22(11):1149-1151.
-
4龙厚玉,王思望,严有望.乙型肝炎病毒表面抗原变异的检测[J].国际流行病学传染病学杂志,2006,33(4):271-274. 被引量:6
-
5潘家普,朱宇杰,刘继纯,龚晓美.心率变异和RT变异频域分析的方法学研究[J].生物医学工程学杂志,1998,15(3):256-261. 被引量:7
-
6凌春原.流行性感冒的预防[J].肇庆医学,2004(2):47-47.
-
7嵇平.缺血性心脏病自主神经系统改变对RT变异及心率变异的影响[J].中国心血管病研究,2004,2(3):214-215. 被引量:1
-
8刘蔚,成军,张连峰,纪冬,刘妍,郭江.拉米夫定治疗乙型肝炎相关失代偿期肝硬化的进展[J].世界华人消化杂志,2004,12(7):1682-1684. 被引量:3
-
9白璐,曲晶.拉米夫定联合阿德福韦酯治疗拉米夫定耐药的乙型肝炎肝硬化患者疗效分析[J].中国实用医药,2013,8(8):145-146. 被引量:2
-
10嵇平.缺血性心脏病自主神经系统改变对RT 变异及心率变异的影响[J].中国心脏起搏与心电生理杂志,2004(z1).